With GPU acceleration becoming a fundamental feature in many HPC facilities, significant development work has been undertaken to allow HemeLB to run on a variety of new generation hardware. With efforts led by Dr Ioannis Zacharoudiou (UCL) and with support from partners across Europe and USA including CompBioMed2 consortium members SURF, Atos and Leibniz Supercomputing Centre (LRZ), Jülich Supercomputing Centre (JSC) and Oak Ridge National Laboratory, we are developing capability to run HemeLB on NVIDIA, AMD and Intel GPUs.
HemeLB Performance Assessment Summary
190x strong-scaling speed-up of HemeLB simulation on SuperMUC-NG
A major effort is now underway to perform the first full scale 3-D high fidelity simulations of blood flow in the human vasculature. Led by Peter Coveney within his Centre for Computational Science (CCS) at University College London (UCL), this major, large scale team endeavour, involves colleagues and collaborators from across Europe and the USA. The members of the team include UCL, Leibniz Supercomputing Centre (LRZ), Jülich Supercomputing Centre (JSC), the IT’IS Foundation and the University of Tennessee at Chattanooga.
Newsletter Issue No. 9, February 2020